Study to evaluate concordance of detecting EGFR (Epidermal Growth Factor Receptor) mutation by circulating tumour free DNA versus tissues biopsy in NSCLC (Non-small cell lung cancer).

Trial Identifier: D5161R00003
Sponsor: AstraZeneca
NCTID:: NCT03562819
Start Date: August 2018
Primary Completion Date: June 2019
Study Completion Date: June 2019

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
India, Chandigarh Punjab, Chandigarh, India, 160055
India, Delhi New Delhi, Delhi, India, 110029
India, Delhi New Delhi, Delhi, India, 110085
India, Delhi New Delhi, Delhi, India, 110063
India, Karnataka Bengaluru, Karnataka, India, 560027
India, Kozhikode Kerala, Kozhikode, India, 673601
India, Maharashtra Mumbai, Maharashtra, India, 400071
India, Maharashtra Mumbai, Maharashtra, India, 400012
India, Mumbai Maharashtra, Mumbai, India, 400016
India, Odisha Bhubaneswar, Odisha, India, 751007
India, Telanagana Hyderabad, Telanagana, India, 500034
India, West Bangal Kolkata, West Bangal, India, 700160
India, West Bengal Kolkata, West Bengal, India, 700054
India, West Bengal Kolkata, West Bengal, India, 700063